January 2025 Journal Club

Please either sign in with your OSU username (e.g. Smith.34324) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: January 2025 Journal Club Article A

1A) Which of the following is a stated adverse side effect of Lithium in the article (Ferenztajn-Rochowiak & Rybakowski ,2-7)

A) Polyuria  B) Swelling  C) Constipation   D) Tacycardia

2A) What does of propranolol is deemed “a potentially effective strategy” when addressing Tremors (Ferenztajn-Rochowiak & Rybakowski,4)?

Article B: January 2025 Journal Club Article B

1B) True or False, the study indicated that metoprolol can improve organ function and reduce 28-day mortality (Ning et al., 1035).

 

Citations

Article A:

Ferensztajn-Rochowiak, E., & Rybakowski, J. K. (2023). Long-term lithium therapy: Side effects and interactions. Pharmaceuticals, 16(1), 74. https://doi.org/10.3390/ph16010074

Article B:

Ning, W., Chen, Y., Lu, J., Zhu, J., & Li, L. (2023). The influence of metoprolol in patients with sepsis-induced cardiomyopathy: A retrospective study. Saudi Medical Journal, 44(10), 1030–1036. https://doi.org/10.15537/smj.2023.44.10.20230149

September 2024 Journal Club

Please either sign in with your OSU username (e.g. Smith.34324) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: September 2024 Journal Club Article A

1A) What was the brief timeline of the longitudinal assessments? (Auerbach, 1010)

A) 5-42 days   B) 43 – 100 days   C) 10-15 minutes    D) 1 year

2A) What assessment was used via smartphone app? (Auerbach, 1012)

A) Bumbler   B) EARS     C) SINK     D) Alto

Article B: September 2024 Journal Club Article B

1B) How many subject reported lifetime suicidal ideation? (Wastler, 1040)

A) 15%   B) 39%   C) 41%   D) 68%

Citations:

Article A: 

Auerbach, R. P., Lan, R., Galfalvy, H., Alqueza, K. L., Cohn, J. F., Crowley, R. N., Durham, K., Joyce, K. J., Kahn, L. E., Kamath, R. A., Morency, L.-P., Porta, G., Srinivasan, A., Zelazny, J., Brent, D. A., & Allen, N. B. (2023). Intensive Longitudinal Assessment of adolescents to predict suicidal thoughts and behaviors. Journal of the American Academy of Child & Adolescent Psychiatry, 62(9), 1010–1020. https://doi.org/10.1016/j.jaac.2023.03.018

Article B:

Wastler, H. M., Cowan, H. R., Hamilton, S. A., Lundin, N. B., Manges, M., Moe, A. M., & Breitborde, N. J. (2023). Variability in suicidal ideation during treatment for individuals at clinical high risk for psychosis: The importance of repeated assessment. Early Intervention in Psychiatry, 17(10), 1038–1041. https://doi.org/10.1111/eip.13413

July 2024 Journal Club

Please either sign in with your OSU user name (e.g. Smith.343236542185) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: July 2024 Journal Club Article A

1A) By how much does The Organization of World Health (WHO) estimate that there will be an increase in mortality caused by cancer (Setiawan, 112)?

A) 13.2 million   B) 3.50 million C) 500 million   D) No data indicates there will ever be an increase in cancer deaths

2A) What physical problems does Guntari’s research NOT indicate for breast cancer patients (Setiawan, 113)?

A) Pain   B) Hair Loss   C) Fatigue   D) Heart murmurs

Article B: July 2024 Journal Club Article B

1B) What was the most frequently reported indirect measure from the various studies (Bonetti, 6)?

A) Quality of life    B) Funding    C) Increased Depression    D) Nausea

Citations:

Article A:

Setiawan, H. (2022). Nursing intervention model to overcome psychosocial problems of breast cancer patients: A literature review. Journal of International Conference Proceedings, 111–120. https://doi.org/10.32535/jicp.v5i4.1916

Article B: 

Bonetti, L., Tolotti, A., Anderson, G., Nania, T., Vignaduzzo, C., Sari, D., & Barello, S. (2022). Nursing interventions to promote patient engagement in cancer care: A systematic review. International Journal of Nursing Studies, 133, 104289. https://doi.org/10.1016/j.ijnurstu.2022.104289

May 2024 Journal Club

Please either sign in with your OSU user name (e.g. Smith.343236542185) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: May 2024 Journal Club Article A 

1A): Which diseases are generally evaluated and considered before ALS? (page 1370) (Feldman et al., 2022)

A)  Small Pox   B) Multifocal Motor Neuropathy with Conduction Block  C) Axonal Motorpredominant Chronic Inflammatory Demyelinating Polyneuropathy  D) Spinobulbar Muscular Atrophy

2A): While no cure for ALS, which two medications can be used (in some countries) for slowing ALS progression? (page 1373) (Feldman et al., 2022)

A)  riluzole      B) acetaminophen   C) edaravone    D) apixaban

 

Article B: May 2024 Journal Club Article B

1A): What type of modality is used to accomplish gene silencing?  (Page 652, box 1) (Akçimen et al., 2023)

A) Mitochondrial Therapeutics    B) Oligonucleotide Therapeutics    C)Polycompositionaligonalitiocalitical-Phase B Therapeutics

Citations:

Article A: Feldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022). Amyotrophic lateral sclerosis. The Lancet, 400(10360), 1363–1380. https://doi.org/10.1016/s0140-6736(22)01272-7

Article B:  Akçimen, F., Lopez, E. R., Landers, J. E., Nath, A., Chiò, A., Chia, R., & Traynor, B. J. (2023). Amyotrophic lateral sclerosis: Translating genetic discoveries into therapies. Nature Reviews Genetics, 24(9), 642–658. https://doi.org/10.1038/s41576-023-00592-y

March 2024 Journal Club

Please either sign in with your OSU user name (e.g. Smith.343236542185) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: eggerthella lenta bacteremia

1A): When was Eggerthella lenta first described (Jiang, 1)? 

A) 1985    B) 1935    C) 1996     D) 1920

2A): What is E. lenta resistant to (Jiang, 2)?

A) metronidazole    B) fluoxetine      C) gabapentin    D) ceftriaxone

Article B: Managing Spontaneous Pneumothorax

1A): What is the 1-year recurrence rate of pneumothrorax (Gottlieb, 568)? 

A) 29%    B) 90%    C) 45%    D) 1%

Citations:

Article A: 

Jiang, S., E, J., Wang, D., Zou, Y., Liu, X., Xiao, H., Wen, Y., & Chen, Z. (2021). Eggerthella lenta bacteremia successfully treated with CEFTIZOXIME: Case report and review of the literature. European Journal of Medical Research, 26(1). https://doi.org/10.1186/s40001-021-00582-y

Article B:

Gottlieb, M., & Long, B. (2023). Managing spontaneous pneumothorax. Annals of Emergency Medicine, 81(5), 568–576. https://doi.org/10.1016/j.annemergmed.2022.08.447

January 2024 Journal Club

Please either sign in with your OSU user name (e.g. Smith.34323) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: Association of SARS-CoV-2 Infection With Serious Maternal Morbidity
and Mortality From Obstetric Complications

1A): What was the major secondary outcome discovered in the study (page 750)?

a) cesarean birth    b) surprise triplets     c) abdominal abscess     d) increased ketones

2A) Which of the following was not a neonatal secondary outcome (page 750)?

a) positive SARS-CoV-2 test result    b) small for gestational age     c) neonatal death      d) large for gestational age

Article B: Noninvasive Bioelectronic Treatment of Postcesarean Pain

1B): What rough percentage of individuals take at least 1 opioid medication after a cesarean delivery (page 2/12)?

a) 50%     b) 80%     c) 60%     d) 70%

2B): What percentage of participants assigned to the electrical stimulation device used less opioid analgesics (page 7/12)?

a) 10%    b) 32%     c) 72%    d) 47%

Citations:

Article A:  Metz, T. D., Clifton, R. G., Hughes, B. L., Sandoval, G. J., Grobman, W. A., Saade, G. R., Manuck, T. A., Longo, M., Sowles, A., Clark, K., Simhan, H. N., Rouse, D. J., Mendez-Figueroa, H., Gyamfi-Bannerman, C., Bailit, J. L., Costantine, M. M., Sehdev, H. M., Tita, A. T., Macones, G. A., … Archer, S. W. (2022). Association of SARS-COV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA, 327(8), 748. https://doi.org/10.1001/jama.2022.1190

Article B: Grasch, J. L., Costantine, M. M., Mast, D. D., Klopfenstein, B., Russo, J. R., Summerfield, T. L., & Rood, K. M. (2023). Noninvasive bioelectronic treatment of Postcesarean pain. JAMA Network Open, 6(10). https://doi.org/10.1001/jamanetworkopen.2023.38188

November 2023 Journal Club

Please either sign in with your OSU user name (e.g. Smith.34323) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: “Long COVID and its Management”

1A): Which of the following is not a systematic concern from Long COVID according to Figure 1, page 4769?

a) Gastric Implosion    b) Myocarditis   c) Metabolic Disorder    d) Kidney Injury

2A):  Which of the following is a proactive measure to relieve potential impacts by Long Covid (pages 4775-4777)? 

a) Bath Salts     b) Anti-Inflammation Treatment    c) Sporanox   d) Horse Paste

Article B: “Long-term cardiovascular outcomes of COVID-19”

1A): All of the following were increased risks of COVID-19 infections except: (pages 583-584)

a) Cerebrovascular disorders    b)  Dysrhythmias      c) Ischemic Heart Disease     d) Jaw Rot

 

Citations:

Article A:  Koc, H. C., Xiao, J., Liu, W., Li, Y., & Chen, G. (2022). Long Covid and its management. International Journal of Biological Sciences, 18(12), 4768–4780. https://doi.org/10.7150/ijbs.75056

Article B:  Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nature Medicine, 28(3), 583–590. https://doi.org/10.1038/s41591-022-01689-3

September 2023 Journal Club

Please either sign in with your OSU user name (e.g. Smith.34323) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: The Effect of Music on Serum Cortisol Levels and Anxiety in Patients
Undergoing Lower Segment Cesarean Section Under Spinal Anesthesia:
A Randomized Controlled Interventional Study

1A): What type of anesthesia is the technique of choice for procedure according to the article? 

a)  Gastritis    b) Collapsed Lung   c) Scrotal Edema      d) Cesarean Section

Article B: 

1B): Which of the following is not an arm that Care Home Units (CHSs) and their residents are allocated into for this study? 

a) group music therapy (GMT)  b) country music television (CMT)  c) recreation choir singing (RCS) d) a combination of both music interventions (GMT & RCS)

Citations:

Article A: Shukla, V., Kaur, H., Bansal, G., Sreehari, S., Harsh, H., & Pareek, R. (2023). The effect of music on serum cortisol levels and anxiety in patients undergoing lower segment cesarean section under Spinal Anesthesia: A randomized controlled interventional study. Journal of Obstetric Anaesthesia and Critical Care, 13(1), 87. https://doi.org/10.4103/joacc.joacc_63_22

Article B: Rasing, N. L., Janus, S. I., Kreutz, G., Sveinsdottir, V., Gold, C., Nater, U. M., & Zuidema, S. U. (2022). The impact of music on stress biomarkers: Protocol of a substudy of the cluster-randomized controlled trial music interventions for dementia and depression in elderly care (middel). Brain Sciences, 12(4), 485. https://doi.org/10.3390/brainsci12040485

July 2023 Journal Club

Please either sign in with your OSU user name (e.g. Smith.34323) or identify yourself as a guest before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

If there is ANY issue posting, please email your comment AND reply to another person to Charles and he will make sure it gets posted.  Please attempt to sign in or use a guest log-in first.

Article A: “Worth A Try” 

1A): In what year, did a systematic review and meta-analysis revealed that it is not
uncommon for general practitioners to prescribe placebos or, more
frequently, non-specific therapies (e.g., vitamins or antibiotics for
common cold)  (Forkmann, Hashim, Bingel, Müßgens, 2022)?

a) 1998        b) 2008     c) 1945       d) 2018

Article B: “Sleep Disturbance and Self-Harm”

1B): How many adolescents in 100,000 are estimated to die by suicide each year (Nguyen, Lerch, Maggetti, Reichl, Tarokh, 2022)? 

a) 6.04         b) 101       c) 8,000       d) 25,000

2B): What years were the study’s participants recruited from(Nguyen, Lerch, Maggetti, Reichl, Tarokh, 2022)? 

a) 1990-2023  b) 2000 – 2005  c) 2013-2019  d) 2023

Citations:

Article A:  Forkmann, K., Hashim, A., Bingel, U., & Müßgens, D. (2022, November 16). Worth a try – A survey on the general acceptance of open-label placebos. https://doi.org/10.1016/j.jpsychores.2022.111096

 (Forkmann, Hashim, Bingel, Müßgens, 2022).

Article B: Nguyen, T. P., Lerch, S., Maggetti, A., Reichl, C., & Tarokh, L. (2022, December 21). The relationship between sleep disturbance and self-harming behaviours in high-risk clinical adolescents. https://doi.org/10.1016/j.jpsychires.2022.12.034

(Nguyen, Lerch, Maggetti, Reichl, Tarokh, 2022).

 

May 2023 Journal Club

Please either sign in with your OSU user name (e.g. Smith.34323) before posting your replies. 

  • Please answer every question by responding with 1A), 2A), 1B), 2B), etc.  You will not be graded on these. 
  • Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice. 
  • Please interact with at least one response in the replies.  I have made the first reply for the first participant (However, you may reply to anyone’s response).  This is considered the interaction between club members and is required as well.

Article A:

1A) What percentage of patients are expected to have possible EPS reactions from haloperidol (Stetson & Osser, 2022, p.172)?

a. 35%  b. 25% c. 50% d. 90%

2A) What percentage of patients are expected to have possible EPS reactions from haloperidol and lorazepam (Stetson & Osser, 2022, p. 173)?

a. 20%  b. 30% c. 80% d. 5%

Article B:

1B) True or False. Higher inflammation hampers response to antidepressants, and effective antidepressant treatment decreases inflammation (Benedetti et al., 2022, p.79).

 

Citations:

Article A)

Stetson, S. R., & Osser, D. N. (2022). Psychopharmacology of agitation in acute psychotic and manic episodes. Current Opinion in Psychiatry, 35(3), 171–176. https://doi.org/10.1097/yco.0000000000000787

      In-text Citation: (Stetson & Osser, 2022)

Article B)

Benedetti, F., Zanardi, R., & Mazza, M. G. (2022). Antidepressant psychopharmacology: Is inflammation a future target? International Clinical Psychopharmacology37(3), 79–81. https://doi.org/10.1097/yic.0000000000000403

      In-text Citation: (Benedetti et al., 2022)